The study not only displays the association of AID and DNMT1 and identifies a novel biological function of AID, but also provides a novel role of a DNMT inhibitor for treating AID-positive hematopoietic cancers. Here, AICDA is linked to hematopoietic and lymphoid cell neoplasm.